Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.21.1
Equity (Tables)
3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
Options Outstanding     Options Exercisable  
Range of
Exercise
Price
    Number
Outstanding at
March 31,
2021
    Weighted Average
Remaining
Contractual Life
(Years)
    Weighted
Average
Exercise
Price
    Number
Exercisable at
March 31,
2021
    Weighted
Average
Exercise
Price
 
$ 0.50       2,000,000       5.86     $ 0.50       2,000,000     $ 0.50  
  1.00 – 1.93       2,810,000       5.37       1.40       2,366,666       1.45  
  2.00 – 2.80       2,740,000       2.52       2.17       2,740,000       2.17  
  4.76       30,000       3.01       4.76       30,000       4.76  
$ 0.50 – 4.76       7,580,000       4.46     $ 1.45       7,136,666     $ 1.47  
Schedule of stock option activities
    Number of
Options
    Weighted
Average
Exercise Price
 
Outstanding at January 1, 2021     7,140,000     $ 1.48  
Granted     440,000       1.12  
Terminated / Exercised / Expired     -       -  
Outstanding at March 31, 2021     7,580,000     $ 1.45  
Options exercisable at March 31, 2021     7,136,666     $ 1.47  
Options expected to vest     443,334     $ 1.14  
Schedule of fair value of the options using the Black-Scholes option-pricing model
    Number of
Options
    Weighted
Average
Exercise
Price
 
Nonvested at January 1, 2021     218,334     $ 1.18  
Granted     440,000       1.12  
Vested     (215,000 )     (1.15 )
Nonvested at March 31, 2021     443,334     $ 1.14